Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Moderna, Inc. (MRNA) had Income from Continuous Operations of $-2.82B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.94B |
|
$-2.82B |
|
$868.00M |
|
$1.08B |
|
$5.02B |
|
$-3.07B |
|
$306.00M |
|
$-2.77B |
|
$-2.77B |
|
$-2.82B |
|
|
Income from Continuous Operations |
$-2.82B |
$-2.82B |
|
$-2.82B |
|
$-3.07B |
|
$-2.93B |
|
389.00M |
|
389.00M |
|
$-7.26 |
|
$-7.26 |
|
| Balance Sheet Financials | |
$6.54B |
|
$2.13B |
|
$5.79B |
|
$12.34B |
|
$1.99B |
|
$610.00M |
|
$1.70B |
|
$3.69B |
|
$8.65B |
|
$8.65B |
|
$8.65B |
|
394.00M |
|
| Cash Flow Statement Financials | |
$-1.87B |
|
$1.95B |
|
$593.00M |
|
$1.93B |
|
$2.60B |
|
$668.00M |
|
$483.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.29 |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
55.35% |
|
-158.13% |
|
-158.13% |
|
-150.51% |
|
-142.39% |
|
-145.16% |
|
$-2.06B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
5.67 |
|
10.57 |
|
34.55 |
|
-32.62% |
|
-32.62% |
|
-22.87% |
|
-30.48% |
|
$21.95 |
|
$-5.31 |
|
$-4.81 |
|